---
title: "Xizang Weixinkang Pharmaceutical released its first-quarter performance, with a net profit attributable to the parent company of 84.54 million yuan, a year-on-year decrease of 10.93%"
type: "News"
locale: "en"
url: "https://longbridge.com/en/news/237598653.md"
description: "According to the Zhitong Finance APP, Xizang Weixinkang Pharmaceutical disclosed its first-quarter report for 2025. During the reporting period, the company achieved revenue of 296 million yuan, a year-on-year decrease of 6.93%; net profit attributable to the parent company was 84.54 million yuan, a year-on-year decrease of 10.93%; and net profit excluding non-recurring gains and losses was 74.35 million yuan, a year-on-year increase of 31.10%. Basic earnings per share were 0.20 yuan"
datetime: "2025-04-25T15:04:03.000Z"
locales:
  - [zh-CN](https://longbridge.com/zh-CN/news/237598653.md)
  - [en](https://longbridge.com/en/news/237598653.md)
  - [zh-HK](https://longbridge.com/zh-HK/news/237598653.md)
generator: "portal-rs"
---

# Xizang Weixinkang Pharmaceutical released its first-quarter performance, with a net profit attributable to the parent company of 84.54 million yuan, a year-on-year decrease of 10.93%

According to the Zhitong Finance APP, Xizang Weixinkang Pharmaceutical (603676.SH) disclosed its first-quarter report for 2025. During the reporting period, the company achieved revenue of 296 million yuan, a year-on-year decrease of 6.93%; net profit attributable to the parent company was 84.54 million yuan, a year-on-year decrease of 10.93%; and net profit excluding non-recurring gains and losses was 74.35 million yuan, a year-on-year increase of 31.10%. The basic earnings per share were 0.20 yuan

### Related Stocks

- [603676.CN](https://longbridge.com/en/quote/603676.CN.md)

## Related News & Research

- [Promise Analyzes Telehealth Licensing Rules as Compact Hits Record 3,633 Licenses in a Month](https://longbridge.com/en/news/296635882.md)
- [US health agencies report 55 cases of E. coli and salmonella infections tied to alfalfa sprouts](https://longbridge.com/en/news/296645342.md)
- [Michaels launches omnichannel custom framing experience with Architectural Digest](https://longbridge.com/en/news/296643293.md)
- [Frozen blueberries recall categorized under FDA's highest Class I risk level](https://longbridge.com/en/news/296506599.md)
- [SandboxAQ introduces AQPotency for virtual drug screening](https://longbridge.com/en/news/296467103.md)

---
> **Disclaimer: This article is for reference only and does not constitute any investment advice.**